Effects of clary sage essential oil inhalation on job stress, anxiety, and sleep of ward new nurses

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011243

Enrollment

Registered

2025-12-03

Start date

2023-12-03

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Clary sage essential oil inhalation) : In the experimental group, clary sage essential oil (Aromarant Co. Ltd.), selected through a preliminary survey, was used. The 100% pure oil was diluted t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants were required to meet all of the following inclusion criteria: (1) individuals who fully understood the purpose of the study and voluntarily agreed to participate; (2) newly graduated nurses working in hospital wards with 3 months to less than 1 year of clinical experience; (3) individuals without any physical illness under treatment and not taking specific medications; (4) individuals with normal olfactory function, with no history of sensorineural or conductive olfactory disorders; (5) individuals who had never been exposed to the scent of clary sage essential oil before the study; and (6) individuals with no allergic reaction to clary sage essential oil.

Exclusion criteria

Exclusion criteria: Participants were excluded if they met any of the following conditions: (1) currently taking specific medications such as anticoagulants or antidiabetic agents; (2) women who were breastfeeding; (3) women who were pregnant; (4) individuals with impaired olfactory function, including those diagnosed with sensorineural or conductive olfactory disorders; (5) individuals who had previously been exposed to the scent of clary sage essential oil before the study; or (6) individuals who had experienced allergic reactions to clary sage essential oil.

Design outcomes

Primary

Measure	Time frame
Changes in occupational stress measured before and after the aromatherapy intervention using the Visual Analogue Scale (VAS).;Changes in anxiety levels measured before and after the aromatherapy intervention using the Visual Analogue Scale (VAS).;Changes in sleep quality measured before and after the aromatherapy intervention using the Visual Analogue Scale (VAS).	—

Secondary

Measure	Time frame
Changes in systolic blood pressure(SBP) measured before and after the aromatherapy intervention using an automated blood pressure monitor(HEM-7142T2, Omron Healthcare Co., Ltd., Kyoto, Japan).;Changes in diastolic blood pressure(DBP) measured before and after the aromatherapy intervention using an automated blood pressure monitor(HEM-7142T2, Omron Healthcare Co., Ltd., Kyoto, Japan).	—

Countries

Korea, Republic of

Contacts

Public ContactCho KyeongHwa

Koera University Guro Hospital

ckh01180@korea.ac.kr+82-2-2626-1322

Outcome results